Article

Cluster headache: new targets and options for treatment

2018-03-20

Abstract excerpt

Cluster headache is a severe headache disorder with considerable impact on quality of life. The pathophysiology of the disease remains poorly understood. With few specific targets for treatment, current guidelines mainly include off-label treatment with medication. However, new targets for possible treatment options are emerging. Calcitonin gene-related peptide (CGRP)-targeted medication could become the first (cl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2d36f57a-919f-5c53-afab-202c2f379db9
DOI: 10.12688/f1000research.13380.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cluster headache: new targets and options for treatmentDOI 10.12688/f1000research.13380.1Read

Migraine Treatment: Towards New Pharmacological TargetsSemantic proximity Read

Neuromodulation in the Management of Cluster Headaches: a Systematic Review and Meta-AnalysisSemantic proximity Read

Cluster Headache and Migraine Shared and Unique Insights: Neurophysiological Implications, Neuroimaging, and Biomarkers: A Comprehensive ReviewSemantic proximity Read

Atogepant: Mechanism of action, clinical and translational scienceSemantic proximity Read

From CGRP to PACAP: Unraveling the Next Chapter in Migraine TreatmentSemantic proximity Read

Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients With Migraine: 3 CasesSemantic proximity Read

Recent advances in the management of migraineSemantic proximity Read

Galcanezumab Add-on in Refractory Cluster HeadacheSemantic proximity Read

Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic PainSemantic proximity Read

Safety efficacy and tolerability of the calcitonin gene-related peptide monoclonal antibodies for migraine prevention in a real world settingSemantic proximity Read

Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity Read

Highly Sensitive Assays for detection of headache inducing neuropeptides, Pituitary adenylate cyclase-activating polypeptide (PACAP) and Calcitonin gene-related peptide (CGRP)Semantic proximity Read